期刊
IMMUNOLOGICAL REVIEWS
卷 239, 期 -, 页码 85-98出版社
WILEY
DOI: 10.1111/j.1600-065X.2010.00966.x
关键词
cervical cancer; NKT cells; papillomavirus infection; immunosuppression; immunoregulation
类别
资金
- National Health and Medical Research Council [351439]
- NIH [1 U01 CA141583-01]
- Cancer Council Australia
- Cancer Research Institute (New York)
- Lions Medical Research Foundation
- Australian Cancer Research Foundation
- Queensland Government
- NATIONAL CANCER INSTITUTE [U01CA141583] Funding Source: NIH RePORTER
The recent development of vaccines prophylactic against human papillomavirus (HPV) infection has the potential to reduce the incidence of cervical cancer globally by up to 70% over the next 40 years, if universal immunization is adopted. As these prophylactic vaccines do not alter the natural history of established HPV infection, immunotherapies to treat persistent HPV infection and associated precancers would be of benefit to assist with cervical cancer control. Efforts to develop immuno-therapeutic vaccines have been hampered by the relative non-immunogenicity of HPV infection, by immunoregulatory processes in skin, and by subversion of immune response induction and immune effector functions by papillomavirus proteins. This review describes HPV-specific immune responses induced by viral proteins, their regulation by host and viral factors, and highlights some conclusions from our own recent research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据